Unidad de Tumores Renales con Afectación Venosa (TRAV), Servicio de Urología, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Unidad de Tumores Renales con Afectación Venosa (TRAV), Servicio de Urología, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Actas Urol Esp (Engl Ed). 2021 Dec;45(10):615-622. doi: 10.1016/j.acuroe.2021.02.009. Epub 2021 Nov 9.
Preoperative renal artery embolization (PRAE) for large renal masses may be performed prior to nephrectomy in order to simplify the procedure and reduce intraoperative bleeding. The objective of this work is to determine the role of PRAE on intraoperative bleeding and postoperative complications in left renal tumors with tumor thrombus limited to the left renal vein (level 0).
Retrospective analysis to evaluate 46 patients who underwent left radical nephrectomy and thrombectomy for the treatment of renal cell carcinoma with level 0 tumor thrombus during the period 1990-2020. PRAE was limited to those cases in which surgical access to the main renal artery was presumed a priori difficult in the preoperative imaging study (n = 9; 19.6%). Intraoperative bleeding was estimated based on the perioperative transfusion rate, and postoperative complications were categorized according to the Clavien-Dindo classification. The Chi-squared test was used for comparisons. A multivariate analysis was performed to identify predictors of transfusion and complications.
There were no significant differences in the overall complication rate (11.1% vs. 32.4%, p = 0.19), major complication rate (0% vs. 8.1%, p = 0.51), or transfusion rate (11.1% vs. 19%, p = 0.49) between both groups (PRAE vs. non-PRAE). In the multivariate analysis, PRAE did not behave as a predictor of complications (OR: 0.11, 95%CI 0.01-2.86; p = 0.18) nor transfusion (OR: 0.46, 95%CI 0.02-7.38; p = 0.58).
In our study on left RCC with level 0 tumor thrombus and difficult access to the main renal artery, PRAE was not associated with increased bleeding or postoperative complications, and it did not behave as an independent predictor of these variables. Therefore, it could be used as a preoperative maneuver to facilitate vascular management in selected cases.
为了简化手术过程并减少术中出血,对于大型肾肿瘤,可以在肾切除术之前进行术前肾动脉栓塞术(PRAE)。本研究的目的是确定 PRAE 在左肾肿瘤中对术中出血和术后并发症的作用,这些肿瘤的肿瘤栓子仅限于左肾静脉(0 级)。
回顾性分析了 1990 年至 2020 年间接受左肾根治性切除术和血栓切除术治疗 0 级肿瘤栓子的肾细胞癌患者 46 例。PRAE 仅限于术前影像学研究中预先假定主要肾动脉手术入路困难的病例(n=9;19.6%)。术中出血量根据围手术期输血率估计,术后并发症根据 Clavien-Dindo 分类进行分类。采用卡方检验进行比较。进行多变量分析以确定输血和并发症的预测因素。
两组间总体并发症发生率(11.1%比 32.4%,p=0.19)、主要并发症发生率(0%比 8.1%,p=0.51)或输血率(11.1%比 19%,p=0.49)均无显著差异(PRAE 组与非 PRAE 组)。多变量分析显示,PRAE 与并发症(OR:0.11,95%CI 0.01-2.86;p=0.18)或输血(OR:0.46,95%CI 0.02-7.38;p=0.58)无关。
在我们的研究中,对于左肾 RCC 伴有 0 级肿瘤栓子和主肾动脉难以进入的病例,PRAE 并未增加出血或术后并发症,也不能作为这些变量的独立预测因素。因此,它可以作为一种术前手段,在选定的病例中有助于血管管理。